Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Tolerability of Rituximab in Neuromyelitis Optica

This study has been completed.
Genentech, Inc.
Information provided by (Responsible Party):
University of California, San Francisco Identifier:
First received: July 12, 2007
Last updated: September 23, 2011
Last verified: September 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2010
  Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)